Ranbaxy Woes Continue With 30-plus Product Import Alert

By PharmAsia News / PharmAsia News Sep. 16, 2008 9:00 AM GMT
Ranbaxy / Word Count: 569 / Article # 28080916001

Executive Summary

FDA will lift a portion of its import alert for generic drugs made in two of Ranbaxy's facilities to allow the company to import antiviral ganciclovir to avoid a drug shortage

Purchase this Article

$35.00 Buy Now

For $35.00, purchase this 569-word article and receive immediate online access. 100% Satisfaction Guarantee.

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: Ranbaxy Woes Continue With 30-plus Product Import Alert

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to PharmAsia News will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel

Ranbaxy Woes Continue With 30-plus Product Import Alert

Executive Summary

Purchase this Article

Already a Subscriber?

Questions?

Related Articles: 20

Elsevier Business Intelligence Publications

Offers & Events

Topics Covered in this Article

Email Article